Prices re-read October 15, 2026Methodology v4.1How we score →
Compare Providers
Home / Editorial board

Released: ·Last reviewed: ·Methodology v4.1

Researched By
Medical Researcher · Western University of Health Sciences
Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

Editorial board

The people who research, write and review Transparent Peptide content — with verifiable credentials.

Clinical reviewers

Review standards

Physician-level medical claims are reviewed by our physician reviewer; clinical-workflow and patient-care content by our nurse-practitioner reviewer; evidence synthesis by our medical researcher. Physician-level medical claims are reviewed by Dr. Jonathan Snipes, MD; clinical-workflow and patient-care content by Kim Callender, NP (FNP-BC); evidence synthesis by Dr. Parmis. Every page names all three in its author block with the date it was last medically reviewed. See correction COR-004 for the history of the physician reviewer credit.

How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.